U.S. class action asserts Ranbaxy manipulated FDA rules

Generic drugmaker Ranbaxy Laboratories Ltd has been sued in a district court in the United States for allegedly manipulating U.S. Food and Drug Administration rules for years to keep rival generic drugs out of the market.

http://in.reuters.com/article/2015/05/14/ranbaxy-lawsuit-usa-idINKBN0NZ1QL20150514

YOU ARE BEING REDIRECTED TO THE ARTICLE
. . .
× CLOSE

PROCESSING